Amylyx Pharmaceuticals (NASDAQ:AMLX) Coverage Initiated at Citigroup
Citigroup began coverage on shares of Amylyx Pharmaceuticals (NASDAQ:AMLX – Free Report) in a research report report published on Tuesday morning, MarketBeat Ratings reports. The firm issued a buy rating and a $12.00 target price on the stock. AMLX has been the topic of a number of other research reports. TD Cowen started coverage on […]
Citigroup began coverage on shares of Amylyx Pharmaceuticals (NASDAQ:AMLX – Free Report) in a research report report published on Tuesday morning, MarketBeat Ratings reports. The firm issued a buy rating and a $12.00 target price on the stock. AMLX has been the topic of a number of other research reports. TD Cowen started coverage on […]
